astragaloside a has been researched along with brusatol in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (brusatol) | Trials (brusatol) | Recent Studies (post-2010) (brusatol) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 89 | 0 | 76 |
| Protein | Taxonomy | astragaloside a (IC50) | brusatol (IC50) |
|---|---|---|---|
| Nuclear factor erythroid 2-related factor 2 | Homo sapiens (human) | 0.0292 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, Z; Tang, B; Wang, L; Xiao, L; Xiao, Q | 1 |
1 other study(ies) available for astragaloside a and brusatol
| Article | Year |
|---|---|
The combination of astragaloside IV and Panax notoginseng saponins attenuates cerebral ischaemia-reperfusion injury in rats through ferroptosis and inflammation inhibition via activating Nrf2.
Topics: Animals; Ferroptosis; Inflammation; NF-E2-Related Factor 2; Panax notoginseng; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins | 2023 |